RT Journal Article
SR Electronic
T1 579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A658
OP A659
DO 10.1136/jitc-2023-SITC2023.0579
VO 11
IS Suppl 1
A1 Mallardo, Domenico
A1 Sparano, Francesca
A1 Vitale, Maria Grazia
A1 Trojaniello, Claudia
A1 Cioli, Eleonora
A1 Esposito, Assunta
A1 Festino, Lucia
A1 Mallardo, Mario
A1 Vanella, Vito
A1 Cristofaro, Teresa De
A1 Facchini, Boanca Arianna
A1 Meinardi, Paolo
A1 Ottaviano, Margaret
A1 Caraco, Corrado
A1 Budillon, Alfredo
A1 Simeone, Ester
A1 Ascierto, Paolo
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A658.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.